United States

Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

11:22am EDT
Change (% chg)

€-0.21 (-1.51%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for GRLSbn.MC


Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)


Beta: 0.19
Market Cap(Mil.): €11,604.23
Shares Outstanding(Mil.): 687.55
Dividend: 0.13
Yield (%): 1.65


  GRLSbn.MC Industry Sector
P/E (TTM): 36.21 36.34 36.24
EPS (TTM): 0.52 -- --
ROI: 6.43 14.45 13.93
ROE: 16.52 15.22 14.87

BRIEF-Medica Sur receives green light to buy LMP

* Said on Wednesday received an approval from a competition watchdog to acquire Laboratorio Medico Polanco (LMP) and its units Laboratorios Clinicos de Puebla (LCP), Laboratorios Clinicosde Puebla en Bioequivalencia (LCPB) and other units

Oct 06 2016

BRIEF-Prim buys branches from Laboratorios Milo for fixed price of 1.2 mln euros

* Buys pharmacy, orthopedics and podiatry branches from Laboratorios Milo for 1.24 million euros ($1.39 million) and variable price depending on results of the branches in 2016-2020 Source text for Eikon:

Sep 12 2016

BRIEF-Grifols' phase I Alzheimer vaccine study shows good safety profile, tolerability

* Says unit Araclon Biotech presents phase I Alzheimer vaccine results showing good safety profile and tolerability

Aug 01 2016

BRIEF-Grifols reports H1 EBITDA at 553.6 mln euros

* H1 net profit 264.4 million euros ($293.1 million) versus 256 million euros in Reuters poll

Jul 28 2016

BRIEF-Grifols to buy a 48,000 square meter plot of land

* To buy a plot of 48,716 square meters to expand its production facilities in Barcelona

Jul 22 2016

Swiss stocks - Factors to watch on July 7

ZURICH, July 7 The Swiss blue-chip SMI was seen opening 0.3 percent higher at 7,921 points on Thursday, according to premarket indications by bank Julius Baer .

Jul 07 2016

BRIEF-SGS buying Laboratorios Contecon Urbar

* Says it's buying Laboratorios Contecon Urbar with operations in Colombia and Panama.

Jul 07 2016

BRIEF-Prim says price of the deal with Laboratorios Milo is not defined

* Says acquisition price of the branches of Laboratorios Milo SA will not be established until the end of negotiations, with the date scheduled for Sept 1

Jun 30 2016

BRIEF-Hologic, Grifols say FDA approves Zika diagnostic test

* FDA has approved use of Procleix Zika virus blood screening assay on Procleix panther system under agency's investigational new drug study protocol

Jun 20 2016

BRIEF-Spain's Grifols targets 1.2 bln euro investments until 2020

* Says it is targeting investments of 1.2 billion euros ($1.4 billion) until 2020 Source text for Eikon: [http://bit.ly/1X03MIC] Further company coverage: ($1 = 0.8921 euros) (Reporting by Madrid Newsroom)

Jun 02 2016

Earnings vs. Estimates